ArticleBMC neurology2025
Assessing cognitive impairment in OSAHS patients through NODDI-based gray matter analysis.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study employed neurite orientation dispersion and density imaging (NODDI) to investigate gray matter microstructural changes in obstructive sleep apnea hypopnea syndrome (OSAHS) patients with cognitive impairment, assessing early diagnostic potential.
methodsThe study comprised 23 OSAHS patients (OSA-NCI group), 43 OSAHS patients with experiencing cognitive impairment (OSA-CI group), and 15 healthy controls (HC group). Fractional anisotropy (FA), neurite density index (NDI), orientation dispersion index (ODI), and volume fraction of isotropic water molecules (Viso) in regions of interest (ROIs) were calculated. Correlations between these parameters and Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) scores were examined. Diagnostic effect was evaluated using receiver operating characteristic (ROC) curve analysis, and area under the curve (AUC) was calculated.
resultsSignificant variations were observed in the NDI, ODI, Viso, and FA. Compared to HCs, the NDI and ODI in the OSA-NCI group decreased, while the Viso value increased. NDI and ODI showed slight increases in the OSA-CI group but remained below HC levels; Viso significantly increased. However, FA did not significantly differ. NDI, ODI, and Viso strongly correlated with MoCA scores in specific gray matter regions; FA showed weak correlations (r < 0.5). ROC analysis confirmed the effectiveness of the NODDI parameters, with average AUC values of 0.689 for the Viso value, 0.676 for the ODI, and 0.635 for the NDI; however, FA showed limited diagnostic utility (AUC 0.452).
conclusionThis study suggests the potential diagnostic utility of NODDI in detecting gray matter pathology in OSAHS patients with cognitive impairment, though further validation in larger, independent cohorts is needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.